FATE THERAPEUTICS INC - 10-Q Filing
Fate Therapeutics reports Q3 financial results including research and development expense updates and milestone-related disclosures.
Tickers: $FATE
Fate Therapeutics reports Q3 financial results including research and development expense updates and milestone-related disclosures.
Tickers: $FATE